Intriguingly, chromosome 1q is amplified in many cancers (Karni-Schmidt et al., 2016) and MDM4 was recently proposed as a driver of recurrent chromosome 1q gains in breast cancer through increased expression of MDM4 and reduced TP53 signaling (Girish et al., 2023). Here, TP53 is linked to cancer.